Archive
SickKids and MyOme Enter Licensing and Research Agreement to Advance DNA Methylation Signatures
IN THE PRESS SickKids and MyOme Enter Licensing and Research Agreement To Advance DNA Methylation Signatures The Hospital for Sick Children (SickKids) and its Industry Partnerships & Commercialization (IP&C) team is pleased to announce a licensing and research agreement with MyOme involving DNA methylation signatures developed through more than a decade of research led by SickKids clinician-scientist Dr. Rosanna Weksberg and her team. The agreement will support clinical validation of existing SickKids-developed signatures using long-read sequencing, as well as continued research to develop additional signatures. “Through our research, we have seen that different variants [...]
Scientists Advance Research Towards New Therapy for Medulloblastoma
NEW PUBLICATION Scientists Advance Research Towards New Therapy For Medulloblastoma Dr. Xi Huang Senior Scientist, Developmental & Stem Cell Biology Dr. Xi Huang, Senior Scientist in the Developmental, Stem Cell & Cancer Biology program at The Hospital for Sick Children (SickKids), has published an exciting new update in his work to develop a novel therapeutic for medulloblastoma, the most common malignant brain tumour in children. After completing extensive screening and investigation into the function of potassium channels in promoting tumour growth, Huang and his research team published findings [...]
